Klas partners with Medicines Discovery Catapult (MDC) in a successful Innovate UK Biomedical Catalyst grant. Following a successful grant application with Innovate UK, generating impressive pilot data, Klas Therapeutics have partnered with MDC in a successful grant application of circa £300,000.
The project seeks to enhance the commercialisation of our exciting new technology, by generating a data package that will confirm the optimal parameters for light activation and dosing regimen. Rendering the technology closer to achieving actual patient benefit while at the same time developing new methods that can be carried forward and translated for the analysis of our eventual clinical data.